Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. - Wikidata - wikimedia - TriplyDB

Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk.

Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk.

http://www.wikidata.org/entity/Q45006133

about

Metabolic syndrome is associated with increased breast cancer risk: a systematic review with meta-analysis Apolipoprotein A-I and Cancer Data-Driven Metabolic Pathway Compositions Enhance Cancer Survival Prediction.Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: a nested case-control study Breast cancer and metabolic syndrome linked through the plasminogen activator inhibitor-1 cycle Serum lipid levels and the risk of biliary tract cancers and biliary stones: A population-based study in China.The cholesterol metabolite 25-hydroxycholesterol activates estrogen receptor α-mediated signaling in cancer cells and in cardiomyocytes Association of metabolic syndromes and risk factors with ampullary tumors development: a case-control study in China.Sex-specific HDL cholesterol changes with weight loss and their association with anthropometric variables: the LIFE study.Metabolic syndrome and mammographic density in Mexican women HDL cholesterol and cancer risk among patients with type 2 diabetes.Metabolic syndrome biomarkers and early breast cancer in Saudi women: evidence for the presence of a systemic stress response and/or a pre-existing metabolic syndrome-related neoplasia risk?The role of high-density lipoproteins in reducing the risk of vascular diseases, neurogenerative disorders, and cancer.The dyslipidemia-associated SNP on the APOA1/C3/A5 gene cluster predicts post-surgery poor outcome in Taiwanese breast cancer patients: a 10-year follow-up study Gene variations in oestrogen pathways, CYP19A1, daily 17β-estradiol and mammographic density phenotypes in premenopausal women.Carcinoembryonic antigen level can be overestimated in metabolic syndrome.Plasma level of LDL-cholesterol at diagnosis is a predictor factor of breast tumor progression.The link between the metabolic syndrome and cancer.Resistin, visfatin, adiponectin, and leptin: risk of breast cancer in pre- and postmenopausal saudi females and their possible diagnostic and predictive implications as novel biomarkers.Serum CA125 concentration has inverse correlation with metabolic syndrome.The metabolic syndrome: A high-risk state for cancer?Correlation Between Obesity and High Density Lipoprotein Cholesterol (HDL-C) in Breast Cancer Patients of Southern Rajasthan.Effects of statin use on volumetric mammographic density: results from the KARMA study.Serum Lipids and Breast Cancer Risk: A Meta-Analysis of Prospective Cohort Studies.Hypochlorite-induced oxidative stress elevates the capability of HDL in promoting breast cancer metastasis.The metabolic syndrome and mammographic breast density in a racially diverse and predominantly immigrant sample of women The Valuable Role of Measuring Serum Lipid Profile in Cancer Progression.Clinical significance of preoperative serum high density lipoprotein cholesterol levels in soft tissue sarcoma.Association of endothelin-1 and matrix metallopeptidase-9 with metabolic syndrome in middle-aged and older adults.27-hydroxycholesterol is an endogenous selective estrogen receptor modulator Obesity, HDL and Breast Cancer.Prediagnostic total and high-density lipoprotein cholesterol and risk of cancer Serum lipid profiles and cancer risk in the context of obesity: four meta-analyses.Lipoprotein subfractions by nuclear magnetic resonance are associated with tumor characteristics in breast cancer.Metabolic syndrome and mammographic density: the Study of Women's Health Across the Nation.Serum lipids, lipoproteins, and risk of breast cancer: a nested case-control study using multiple time points.Metabolic profile of breast cancer in a population of women in southern Spain.The role of chronic inflammation in obesity-associated cancers.HDL-cholesterol and incidence of breast cancer in the ARIC cohort study.Cardiometabolic factors and breast cancer risk in U.S. black women.

P2860

Q23920590-59395776-C073-4C62-BDF5-FD526E166AFE Q26776188-AC3E405B-48E3-41A8-9E3B-8DEF02FD56AC Q31133387-774A8FC4-BB6E-46FA-BF5C-B250FF7B4B6E Q33643001-C8B7E9CA-EE89-46A3-88CC-97A72C6D8C7C Q33715393-F651780D-C3DC-429C-9E3C-540DD33F9CCC Q33814914-52721E2B-CCD4-430A-92DA-1A970155C7DB Q33815579-A0FED9E1-C9E4-4B11-92E3-F4AA727F7788 Q33948411-FED0B612-9A35-4980-A5F7-6038DA611C9C Q34486587-4CE609E7-C515-440B-A62C-1E115E48876D Q34488889-A5038EA5-B429-4BAE-A5B8-E4B78B3535B0 Q34545361-5073A76B-CE02-48CE-8DD5-BC6F036A5342 Q34572361-4EF36CF5-F1E3-4850-B728-B7A3AB1C5F5C Q34730815-F476DD87-7014-4EBD-A268-789461E3FA9B Q34799703-C6FD54D5-5414-4FFE-871B-1D42E3846FD5 Q35000723-F13E7888-DB6C-4A65-9F34-66CE8602929B Q35009846-B5FF088D-7418-47C7-9C6D-7B10FF96FDD2 Q35103289-7098C424-1DAD-4BDC-8670-5DA9DA4482C4 Q35187561-CE968D83-A302-414F-B0C0-EC2B5A58A5EC Q35206787-949417FE-05B3-4404-81D5-A67EDB2D9169 Q35333807-A3193A07-6650-46D9-B6E2-71DB2A8591FE Q35607405-AD49B8D3-9D9B-46A4-92EB-DE3B4C0BE656 Q35628081-02E2CA8C-C992-4B67-B0E4-6A4D6553110E Q35643266-61457844-51DA-44C0-A722-0D5783B6029E Q35836964-CD9A5E16-F26A-4C30-B0EB-3BF47C4D2E36 Q35927813-1007C9F4-1767-4DE9-8651-C323E3DA62A6 Q36054359-95758114-3026-4DCA-844B-EDC882B0ECE9 Q36076874-7CB22F6C-40F5-475A-B4C5-35F0B411F858 Q36151318-A5D1FE09-8C0F-481D-A139-BAE792D5CCAA Q36364214-1037277E-5364-408C-93A2-EEB86DDF519D Q36372645-B2A2D83E-847A-48D2-93D3-1B24D94CDACB Q36464684-845238FE-A066-49BB-9392-D7321D05B300 Q36501079-99FB5842-D4FA-475A-B0FA-DEBDD19775A8 Q36584255-352FEC79-3F52-4948-994A-FDC1A5D7EF0C Q36680439-E1D7F2F7-E8C6-46AD-9CFF-2096D86827BE Q36723813-8B787629-E7E2-4854-AAF0-042A78E7AA42 Q36770247-62481B45-9103-4AF9-A5C3-340644977520 Q36798413-1D957356-B01F-4271-9349-7ADFAC10BA3F Q36931512-1E7E90DF-86E3-4383-AE86-5EB31ECA15E4 Q36934633-28B57E56-D558-45DF-BB22-390730C2967A Q36942881-07FE2025-D040-4F06-85B8-F4BB9A9FD29E

P2860

Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk.

http://www.wikidata.org/entity/Q45006133

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk.

@en

Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk.

@nl

type

label

Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk.

@en

Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk.

@nl

prefLabel

Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk.

@en

Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk.

@nl

P1433

Q45006133-7D0F209C-C9BD-4BD9-8F15-A136400D7271

P1476

Q45006133-B6568A8B-CA11-424B-8C30-3E32DE54DD8C

P2093

Q45006133-012ABBB5-873C-41E5-BFF9-5654DE0F802B

Q45006133-356A9BA6-B37F-4E8B-ACE2-A0F1D3B042FE

Q45006133-491DE5AD-D55D-46CF-840B-985FC06F4EF9

P2860

Q45006133-076C2332-A5C0-4201-93D6-B4A7E5D0CA4E

Q45006133-38773980-475F-48DD-A299-37178694FD55

Q45006133-3F1D7899-A489-44CC-AF70-F575B5C63FA1

Q45006133-448791C1-F9DD-480B-A799-D298118DFCD2

Q45006133-4918998C-FDD2-44C6-AE97-DF671189A83C

Q45006133-68111AF0-2E48-4621-9EFB-D3758D291897

Q45006133-70B0D9BB-5705-460F-8672-1BAD9F0DA2ED

Q45006133-73B7F6A6-E84D-401F-A3C9-B9CC4001E3F1

Q45006133-748207C2-6913-48FE-AEAF-10BF9CC2F311

Q45006133-8CBF1804-500D-486C-ACF4-1ECC619A0730

P304

Q45006133-446BBF31-1509-429F-AEEE-615D37AA9773

P31

Q45006133-238A206C-B767-439A-AD81-1099C5015B77

P356

Q45006133-625ADC1D-9029-43AD-90AD-5244ABC156FB

P407

Q45006133-36F15253-E934-40E0-8C85-F23BCEF227D7

P433

Q45006133-C2B2ABC1-3CAE-4EE9-97E8-E827EA2D2069

P478

Q45006133-2578B0A2-A905-4EF5-9163-33B2A095F998

P50

Q45006133-13B3742C-ADFB-41BF-9E6C-5DA935BC26E2

Q45006133-586C7AF0-0B83-4BC0-8EB9-38439D453AC1

P577

Q45006133-50721F75-2FCC-434A-AEA8-BC24AB659D30

P5875

Q45006133-BC9AEA16-4C51-4A1E-BCA5-9A742497533A

P698

Q45006133-DA8E58ED-2DCB-49A4-82F5-B2626427F788

P921

Q45006133-C7695B3E-9647-4893-A294-300356F62E5B

P356

P1433

Journal of the National Cancer Institute

P1476

Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk.

@en

P2093

Anne-Sofie Furberg

http://www.w3.org/2001/XMLSchema#string

Inger Thune

http://www.w3.org/2001/XMLSchema#string

Tom Wilsgaard

http://www.w3.org/2001/XMLSchema#string

P2860

Role of lipids, lipoproteins and vitamins in women with breast cancer.

Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer. Study of Osteoporotic Fractures Research Group.

Western nutrition and the insulin resistance syndrome: a link to breast cancer.

Distribution of high-density lipoprotein cholesterol according to age, sex, and ethnic origin: cardiovascular disease study in Finnmark 1977.

Role of the insulin-like growth factor family in cancer development and progression.

Roles of androgens in the development, growth, and carcinogenesis of the mammary gland.

Evaluation of the synergistic effect of insulin resistance and insulin-like growth factors on the risk of breast carcinoma

Plasma lipids and prolactin in patients with breast cancer

IGF1 genotype, mean plasma level and breast cancer risk in the Hawaii/Los Angeles multiethnic cohort.

Quality of prostate cancer data in the cancer registry of Norway.

P304

1152-1160

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/DJH216

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

96

http://www.w3.org/2001/XMLSchema#string

P50

Marit B. Veierød

Leslie Bernstein

P577

2004-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8418963

http://www.w3.org/2001/XMLSchema#string

P698

15292387

http://www.w3.org/2001/XMLSchema#string

P921